Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Amitriptyline

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 64Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Health Canada Issues Recall of AA Pharma's Amitriptyline antidepressant drugs
    Health Canada Issues Recall of AA Pharma's Amitriptyline antidepressant drugs

    07 Feb 2023

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/amitriptyline-antidepressant-drugs-recalled-because-nitrosamine-impurity

    HEALTH CANADA
    07 Feb 2023
    Share Share
    Health Canada Issues Recall of Apotex's APO-AMITRIPTYLINE 10mg: NDMA Impurity
    Health Canada Issues Recall of Apotex's APO-AMITRIPTYLINE 10mg: NDMA Impurity

    07 Feb 2023

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/apo-amitriptyline-10mg-ndma-impurity-0

    HEALTH CANADA
    07 Feb 2023
    Share Share
    AlgoTx begins Phase II trial of neuropathy pain relief treatment
    AlgoTx begins Phase II trial of neuropathy pain relief treatment

    02 Sep 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/algotx-neuropathy-pain-relief/

    CLINICALTRIALSARENA
    02 Sep 2022
    Share Share
    Algo Announces Initiation of Global Phase 2 Clinical Trial of ATX01
    Algo Announces Initiation of Global Phase 2 Clinical Trial of ATX01

    01 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220901005014/en

    BUSINESSWIRE
    01 Sep 2022
    Share Share
    Micro Labs' Generic Chlordiazepoxide & Amitriptyline Receives Approval in U.S.
    Micro Labs' Generic Chlordiazepoxide & Amitriptyline Receives Approval in U.S.

    02 Feb 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211925

    FDA
    02 Feb 2022
    Share Share
    Enforcement Report - Week of February 28, 2018
    Enforcement Report - Week of February 28, 2018

    28 Feb 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf

    FDA
    28 Feb 2018
    Share Share